Intervention Protocol

You have full text access to this OnlineOpen article

Lurasidone versus placebo for schizophrenia

  1. Lorna Donnelly1,*,
  2. Stephanie Sampson2

Editorial Group: Cochrane Schizophrenia Group

Published Online: 28 MAR 2013

DOI: 10.1002/14651858.CD010448

How to Cite

Donnelly L, Sampson S. Lurasidone versus placebo for schizophrenia (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 3. Art. No.: CD010448. DOI: 10.1002/14651858.CD010448.

Author Information

  1. 1

    Norfolk and Suffolk Foundation Trust, Acute Psychiatric Services, Bury St Edmunds, Suffolk, UK

  2. 2

    The University of Nottingham, Cochrane Schizophrenia Group, Nottingham, UK

*Lorna Donnelly, Acute Psychiatric Services, Norfolk and Suffolk Foundation Trust, Wedgewood House, West Suffolk Hospital, Hardwick Lane, Bury St Edmunds, Suffolk, IP332QZ, UK. lornadonnelly@doctors.org.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 28 MAR 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To review the effects of lurasidone compared with placebo for people with schizophrenia.